Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
16 December 2017 |
Main ID: |
NCT02253784 |
Date of registration:
|
29/09/2014 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Comparison Between Perineural and Systemic Effect of Dexamethasone as an Adjuvant for Prolongation of Four Nerve Blocks With Bupivacaine in Total Knee Arthroplasty
|
Scientific title:
|
|
Date of first enrolment:
|
October 2014 |
Target sample size:
|
90 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT02253784 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: Single (Investigator).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Israel
| | | | | | | |
Contacts
|
Name:
|
Anatoly Stav, MD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Hillel Yaffe Medical Center |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Pre-surgical total knee arthroplasty patients
Exclusion Criteria:
- Skin infection near block site
- Allergy to local anesthetics
- Peripheral neuropathy
- Proven opioid dependency
- Coagulopathy
- Dementia
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Pain, Postoperative
|
Analgesia
|
Intervention(s)
|
Drug: Bupivacaine
|
Drug: Dexamethasone
|
Primary Outcome(s)
|
Efficacy Perineural DxaM
[Time Frame: One day]
|
Secondary Outcome(s)
|
Efficacy of Systemic DxaM
[Time Frame: One day]
|
Secondary ID(s)
|
14-XX-HYMC
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|